| 35 |
Cardiogenic Shock: the Role of Cath-Lab Team |
Young Seo Lee |
May. 26. 25 |
| 34 |
PADN for IpcPH: Pilot Results |
Shao-Liang Chen |
Apr. 17. 25 |
| 33 |
PADN-CFDA Trial |
Yucheng Chen |
Apr. 17. 25 |
| 32 |
PADN-5 Study |
Hang Zhang |
Apr. 17. 25 |
| 31 |
Pulmonary Artery Denervation for PH |
Wei Zhuang |
Apr. 17. 25 |
| 30 |
Current Status of PAH Treatment in Korea |
Dae-Hee Kim |
Apr. 17. 25 |
| 29 |
Controversies in Medical Therapy for Ischemic Cardiomyopathy |
Jeehoon Kang |
Apr. 17. 25 |
| 28 |
Management Strategies for Severe Ischemic Heart Disease: When CABG Is Not an Option |
Imad Sheiban |
Apr. 17. 25 |
| 27 |
PCI in Ischemic Cardiomyopathy: Current & Future Perspectives |
Joo Myung Lee |
Apr. 17. 25 |
| 26 |
CABG in Patients With Impaired Ventricular Function: Indications and Outcomes |
David Paul Taggart |
Apr. 17. 25 |
